Pflug Koory’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$768K Hold
994
0.35% 68
2025
Q4
$767K Sell
994
-12
-1% -$8.15K 0.36% 68
2025
Q3
$566K Hold
1,006
0.27% 86
2025
Q2
$528K Sell
1,006
-2
-0.2% -$1.12K 0.27% 86
2025
Q1
$639K Sell
1,008
-32
-3% -$22K 0.36% 71
2024
Q4
$741K Sell
1,040
-8
-0.8% -$6.71K 0.38% 68
2024
Q3
$1.1M Buy
+1,048
New +$1.17M 0.54% 55
2024
Q1
$1.04M Sell
1,078
-5
-0.5% -$4.75K 0.51% 61
2023
Q4
$951K Sell
1,083
-15
-1% -$12.4K 0.5% 59
2023
Q3
$904K Hold
1,098
0.52% 57
2023
Q2
$789K Sell
1,098
-15
-1% -$11.6K 0.4% 70
2023
Q1
$915K Sell
1,113
-30
-3% -$22.6K 0.5% 58
2022
Q4
$825K Sell
1,143
-3
-0.3% -$2.21K 0.46% 65
2022
Q3
$789K Sell
1,146
-14
-1% -$8.81K 0.48% 65
2022
Q2
$686K Hold
1,160
0.4% 72
2022
Q1
$810K Hold
1,160
0.41% 72
2021
Q4
$733K Hold
1,160
0.37% 73
2021
Q3
$702K Hold
1,160
0.38% 76
2021
Q2
$648K Hold
1,160
0.34% 84
2021
Q1
$549K Sell
1,160
-31
-3% -$15.1K 0.3% 89
2020
Q4
$575K Buy
1,191
+63
+6% +$34K 0.34% 82
2020
Q3
$631K Sell
1,128
-5
-0.4% -$3.03K 0.43% 66
2020
Q2
$707K Hold
1,133
0.52% 56
2020
Q1
$553K Buy
1,133
+625
+123% +$258K 0.49% 61
2019
Q4
$191K Buy
+508
New +$171K 0.14% 150

Other funds holding REGN

Pflug Koory's REGN Position: Q1 2026 in Review

Pflug Koory held its Regeneron Pharmaceuticals (REGN) position steady in Q1 2026 at 994 shares worth $768K. The position accounts for 0.35% of the portfolio, ranked #68.

Pflug Koory first reported a position in REGN in Q4 2019 and has held it in 25 quarters since. The position peaked at $1.1M in Q3 2024. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • Pflug Koory held 994 shares of Regeneron Pharmaceuticals worth $768K as of Q1 2026.
  • Pflug Koory left its Regeneron Pharmaceuticals share count unchanged in Q1 2026.
  • Regeneron Pharmaceuticals made up 0.35% of Pflug Koory's portfolio in Q1 2026, its #68 holding.
  • Pflug Koory first reported a position in Regeneron Pharmaceuticals in Q4 2019 and has held it in 25 quarters since.
  • Pflug Koory's Regeneron Pharmaceuticals position peaked at $1.1M in Q3 2024.
  • 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on Pflug Koory's 13F filing for Q1 2026, filed 22 Apr 2026.